Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Immunis announced it raised $12 Million in an initial filing from an offering of $12 Million

PRIVATEJun 15, 2026•about 2 months ago

Amount Raised

$12 Million

Round Type

Venture - Series Unknown

IrvineBiotechnology

Company Information

Company

Immunis

Location

N Stephenson Hwy

Irvine, California, United States

About

About Immunis Inc.Immunis is a private biotechnology company developing a novel immunomodulatory secretome product for the various manifestations of age and disease-related immune decline.

Don't miss Immunis's next move

Get an email the moment Immunis raises, hires an exec, or expands — usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
2 contacts
Verified contactsMark C., Chief Business Officer and Head of Fina… hidden hidden hidden
Predictive Intelligence
Strategic

ML-powered predictions for Immunis's next move

Learn about Strategic plan

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.